Bellerophon Therapeutics, Inc.·4

Nov 19, 4:36 PM ET

Fernandes Peter 4

4 · Bellerophon Therapeutics, Inc. · Filed Nov 19, 2019

Insider Transaction Report

Form 4
Period: 2019-11-15
Fernandes Peter
Chief Regulatory Officer
Transactions
  • Tax Payment

    Common Stock

    2019-11-15$0.34/sh40,280$13,695182,022 total

Documents

1 file
  • 4
    wf-form4_157419937340865.xmlPrimary

    FORM 4